Molecule Partners with CryoDAO to Expand Onchain Intellectual Property and Advance Cryopreservation Research
Molecule, a leader in decentralized science (DeSci) and a pioneer in tokenized intellectual property (IP), is thrilled to announce its strategic partnership with CryoDAO.
Jillian Casalini
Molecule, a leader in decentralized science (DeSci) and a pioneer in tokenized intellectual property (IP), is thrilled to announce its strategic partnership with CryoDAO, a decentralized collective dedicated to funding high-impact research to advance cryopreservation techniques.
Working on the bleeding edge of scientific innovation, CryoDAO’s mandate is to make death optional. We will be working together to further their mission, bringing cryopreservation research projects to the DeSci community utilizing Molecule IP tokens: IP-NFTs and IPTs.
Powered by Molecule IP Tokens
Molecule IP tokens transform the management of scientific IP through tokenization:
- Intellectual Property NFTs (IP-NFTs): IP-NFTs are non-fungible tokens that register scientific IP onchain. IP-NFTs provide a secure, immutable record of scientific IP ownership and rights, enabling easy IP transfer, verification, and management.
- Intellectual Property Tokens (IPTs): IPTs are fungible tokens that distribute the IP rights associated with a particular IP-NFT, decentralizing its scientific process by enabling globally distributed governance of it and transforming the way scientists engage with their online communities.
Molecule IP-NFTs and IPTs empower CryoDAO to accelerate the pace of cryopreservation research and funding by bringing scientific IP onchain.
Combining Biotech Dealflow Expertise
Working closely with the CryoDAO scientific research dealflow team, Molecule’s biotech team will aid in experimental planning, IP strategy, and negotiation, leveraging an existing partnership with Nucleate.
You can learn more about Molecule’s partnership with Nucleate to source cutting-edge scientific research for IP tokenization from all around the world here.
Together, CryoDAO and Molecule will build a pipeline of groundbreaking cryopreservation research projects and tokenize them.
Growing Onchain IP Through Cryopreservation
This collaboration marks an important step towards a more vibrant and innovative DeSci ecosystem, leveraging the strengths of both organizations to make a meaningful impact. To stay up to date on the partnership, follow Molecule on X or sign up for our newsletter.
About the author
Jillian Casalini
I'm a biotech strategist and marketer with a foundation in traditional pharma and a vision for decentralized innovation. My career began in traditional pharma at Eli Lilly, where I learned how large-scale organizations bring rigor, regulation, and reach to life sciences. I also built a strong foundation in go-to-market strategy—bridging science with storytelling and turning complex research into clear, compelling narratives. That experience now fuels my passion for building at the intersection of biotech and decentralized science (DeSci)—where transparency, open collaboration, and new funding models are reshaping how research gets done.
Related Posts
Science IP Tokens /acc
Molecule’s original Science IP Token framework introduced a new primitive for science – a governance token linked directly to scientific IP.
Building the Hypothesis-to-IP Flywheel: BioAgents, ResearchHub & Molecule
In the early days of DeFi, growth exploded when builders started creating permissionless integrations around building blocks; collateralized debt positions, decentralized exchanges, lending protocols.
One Interface for Onchain Science: Molecule Labs Has Arrived
Don’t Trust, Verify. For Science.